Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Fiaux, E ^a   Titecat, M ^b   Robineau, O ^c   Lora Tamayo, J ^d   El Samad, Y ^e   Etienne, M ^a   Frebourg, N ^a   Blondiaux, N ^c   Brunschweiler, B ^e   Dujardin, F ^a   Beltrand, E ^c   Loiez, C ^b   Cattoir, V ^f   Canarelli, J P ^e   Hulet, C ^f   Valette, M ^c   Nguyen, S ^c   Caron, F ^a   Migaud, H ^b   Senneville, E ^c,g  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Gustave Dron Hospital   (France)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

^g Hospital University   (France)

Author keywords

Outcome; Prosthetic joint infection; Rifampicin; Risk factors; Streptococcus spp

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; ANTIINFECTIVE AGENT;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTEROCOCCUS DURANS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; OBSERVATIONAL STUDY; PROGNOSIS; PROSTHESIS INFECTION; PROSTHETIC JOINT INFECTION; REMISSION; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; TREATMENT OUTCOME; ADVERSE EFFECTS; ARTHRITIS; CLINICAL TRIAL; COMBINATION DRUG THERAPY; HIP PROSTHESIS; KNEE; KNEE PROSTHESIS; KNEE REPLACEMENT; MICROBIOLOGY; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; STREPTOCOCCAL INFECTIONS; SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS; ARTHROPLASTY, REPLACEMENT, KNEE; DRUG THERAPY, COMBINATION; FEMALE; HIP PROSTHESIS; HUMANS; KNEE JOINT; KNEE PROSTHESIS; LEVOFLOXACIN; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RIFAMPIN; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84992052448     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1889-0     Document Type: Article

References (29)

1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
2. Odum SM, Fehring TK, Lombardi AV, Zmistowski BM, Brown NM, Luna JT, et al. Irrigation and debridement for periprosthetic infections: does the organism matter? J Arthroplasty. 2011;26(Suppl):114-8.
3. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR. Outcome of penicillin susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003;36:845-49.
4. Everts RJ, Chambers ST, Murdoch DR, Rothwell AG, McKie J. Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. ANZ J Surg. 2004;74:210-14.
5. Betz M, Abrassart S, Vaudaux P, Gjika E, Schindler M, Billières J, et al. Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus with debridement, antibiotics and implant retention compared to Streptococcus spp. Int Orthop. 2015;39:397-401.
6. Zeller V, Lavigne M, Biau D, Leclerc P, Ziza JM, Mamoudy P, et al. Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections. Jt Bone Spine Rev Rhum. 2009;76:491-6.
7. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1-10.
8. Gilbert P, Collier PJ, Brown MR. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother. 1990;34:1865-8.
9. Zimmerli W, Widmer A, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537-41.
10. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, et al. Effectiveness and safety of rifampicin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010;29:961-7.
11. Senneville E, Joulie D, Legout L, Valette M, Dezèque H, Beltrand E, et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis. 2011;53:334-40.
12. Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sanchez-Somolinos M, Baraia-Etxaburu JM, et al. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2013;56:182194.
13. Trampuz A, Perka C, Borens O. Prosthetic joint infection: new developments in diagnosis and treatment. Dtsch Med Wochenschr. 2013;138:1571-3.
14. Boselli E, Allaouchiche B. Diffusion in bone tissue of antibiotics. Presse Med. 1999;28:2265-76.
15. Forrest GN, Tamura K. Rifampicin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010;23:14-34.
16. Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J. 2013;95:1450-2.
17. Holmberg A, Morgelin M, Rasmussen M. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother. 2012;67:433-9.
18. Zürcher-Pfund L, Uçkay I, Legout L, Gamulin A, Vaudaux P, Peter R. Pathogen-driven decision for implant retention in the management of infected total knee prostheses. Int Orthop. 2013;37:1471-5.
19. Sendi P, Christensson B, Uçkay I, Trampuz A, Achermann Y, Boggian K, et al. BGS PJI study group. Group B streptococcus in prosthetic hip and knee joint-associated infections. J Hosp Infect. 2011;79:64-9.
20. Duggan JM, Georgiadis G, VanGorp C, Kleshinski J. Group B streptococcal prosthetic joint infections. J South Orthop Assoc. 2001;10:209-14.
21. Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, et al. European Society Group of Infections on Artificial Implants (ESGIAI). Characteristics of prosthetic joint infections due to Enterococcus sp and predictors of failure: a multi-national study. Clin Microb Infect. 2014;11:1219-24.
22. Pasquantonio G, Condo S, Cerroni L, Bikiqu L, Nicoletti M, Prenna M, Ripa S. Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity. Int J Immunopathol Pharmacol. 2012;25:805-9.
23. Vesely JJ, Pien FD, Pien BC. Rifampicin, a useful drug for nonmycobacterial infections. Pharmacotherapy. 1998;18:345-57.
24. Buller LT, Sabry FY, Easton RW, Klika AK, Barsoum WK. The preoperative prediction of success following irrigation and debridement with polyethylene exchange for hip and knee prosthetic joint infections. J Arthroplasty. 2012;27:757-854.
25. Vilchez F, Martínez-Pastor JC, García-Ramiro S, Bori G, Maculé F, Sierra J, et al. Efficacy of debridement in hematogenous and early post-surgical prosthetic joint infections. Int J Artif Organs. 2011;34:863-9.
26. Rodríguez D, Pigrau C, Euba G, Cobo J, García-Lechuz J, Palomino J, et al. REIPI Group (Spanish Network for Research in Infectious Disease). Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management. Clin Microbiol Infect. 2010;16:1789-95.
27. Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis). Société de Pathologie Infectieuse de Langue Française (SPILF); Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT); Groupe de Pathologie Infectieuse Pédiatrique (GPIP); Société Française d'Anesthésie et de Réanimation (SFAR); Société Française de Chirurgie Orthopédique et Traumatologique (SOFCOT); Société Française d'Hygiène Hospitalière (SFHH); Société Française de Médecine Nucléaire (SFMN); Société Française de Médecine Physique et de Réadaptation (SOFMER); Société Française de Microbiologie (SFM); Société Française de Radiologie (SFR-Rad); Société rançaise de Rhumatologie (SFR-Rhu). Med Mal Infect. 2009;39:745-74.
28. Nguyen S, Robineau O, Titecat M, Blondiaux N, Valette M, Loiez C, et al. Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections. Eur J Clin Microbiol Infect Dis. 2015;4:1675-82.
29. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994;33:959-67.